Spectra Products Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Spectra Products şirketinin toplam hissedar öz sermayesi CA$1.8M ve toplam borcu CA$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$2.2M ve CA$371.3K dir. Spectra Products 'in FAVÖK'ü CA$109.0K faiz karşılama oranı -3.2 dur. Şirketin CA$1.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

CA$0

Borç

Faiz karşılama oranı	-3.2x
Nakit	CA$1.44m
Eşitlik	CA$1.81m
Toplam yükümlülükler	CA$371.30k
Toplam varlıklar	CA$2.18m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Is Spectra Products Inc.'s(CVE:SSA) Recent Stock Performance Tethered To Its Strong Fundamentals?

Mar 08

With EPS Growth And More, Spectra Products (CVE:SSA) Is Interesting

Jan 13

Is Weakness In Spectra Products Inc. (CVE:SSA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 08

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SSA 'nin kısa vadeli varlıkları ( CA$2.0M ) kısa vadeli yükümlülüklerini ( CA$202.1K ) aşıyor.

Uzun Vadeli Yükümlülükler: SSA şirketinin kısa vadeli varlıkları ( CA$2.0M ) uzun vadeli yükümlülüklerini ( CA$169.2K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SSA borçsuzdur.

Borcun Azaltılması: SSA un 5 yıl önce borcu yoktu.

Borç Kapsamı: SSA un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: SSA şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Spectra Products Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.006 in 3Q 2023)

Now 23% undervalued

Second quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.008 in 2Q 2023)

Spectra Products Inc. (CVE:SSA) Investors Are Less Pessimistic Than Expected

First quarter 2024 earnings released: EPS: CA$0.003 (vs CA$0.006 in 1Q 2023)

Now 23% overvalued

Spectra Products Inc.'s (CVE:SSA) Share Price Not Quite Adding Up

Spectra Products Inc., Annual General Meeting, Mar 19, 2024

Third quarter 2023 earnings released: EPS: CA$0.006 (vs CA$0.006 in 3Q 2022)

Spectra Products Inc. Announces Appointment of John Dynes as New Director

A Look At The Intrinsic Value Of Spectra Products Inc. (CVE:SSA)

Second quarter 2023 earnings released: EPS: CA$0.008 (vs CA$0.003 in 2Q 2022)

First quarter 2023 earnings released: EPS: CA$0.006 (vs CA$0.002 in 1Q 2022)

Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.017 in FY 2021)

Spectra Products Inc. Announces CFO Changes

A Look At The Intrinsic Value Of Spectra Products Inc. (CVE:SSA)

Spectra Products Inc., Annual General Meeting, Feb 15, 2023

Third quarter 2022 earnings released: EPS: CA$0.001 (vs CA$0.006 in 3Q 2021)

Now 29% undervalued after recent price drop

Now 25% undervalued

Now 24% undervalued

A Look At The Intrinsic Value Of Spectra Products Inc. (CVE:SSA)

Second quarter 2022 earnings released: EPS: CA$0.001 (vs CA$0.001 in 2Q 2021)

Spectra Products Inc. Announces Board Changes

First quarter 2022 earnings released

Full year 2021 earnings released: EPS: CA$0.003 (vs CA$0.005 in FY 2020)

Third quarter 2021 earnings released: EPS CA$0.001 (vs CA$0.001 in 3Q 2020)

First quarter 2021 earnings released: EPS CA$0.001 (vs CA$0.002 in 1Q 2020)

Full year 2020 earnings released: EPS CA$0.005 (vs CA$0.011 in FY 2019)

Does Spectra Products (CVE:SSA) Deserve A Spot On Your Watchlist?

Is Spectra Products Inc.'s(CVE:SSA) Recent Stock Performance Tethered To Its Strong Fundamentals?

With EPS Growth And More, Spectra Products (CVE:SSA) Is Interesting

Is Weakness In Spectra Products Inc. (CVE:SSA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Third quarter earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin